And a billionaire’s son has challenged his $35m legal bill from one of the world’s top law firms.
ArborGen chair battles virus – and public attitudes.
The Palmerston North manufacturer now has the same owner as an Italian pharma giant.
Greenfern hopes to raise $4m ahead of an IPO next year.
A new outbreak won't push the deal off the table - but it would devalue it.
High wholesale electricity prices, lots of wind propels $11.5m in revenue.
UPDATE: NZX says it has been working with cyber security provider Akamai Technologies
Cashed-up returnees are buying properties sight unseen - and outbidding locals.
Art and print publications enthusiast now runs his own publishing house in Whanganui.
The NZX-listed medicinal cannabis company's share price had almost tripled in the last three weeks.